Evaluation of prognosis by complete blood parameters in patients with acute pulmonary embolism

Background: Acute pulmonary embolism is associated with high death and morbidity. During a pulmonary embolism, neutrophils infiltrate the right ventricular wall, inflammatory mediators are released, and necrosis develops. This study aimed to compare the effectiveness of whole blood parameters mean platelet volume (MPV), mean platelet volume to platelet ratio (MPVPR), neutrophils (NEU), neutrophil-to-lymphocyte platelet ratio (NLPR), neutrophil to lymphocyte ratio (NLR), neutrophil to platelet ratio (NPR), platelets (PLT), platelet mass index (PMI), and systemic immune-inflammatory index (SII) in predicting mortality in patients with acute pulmonary embolism. Methods: We retrospectively analyzed 112 patients diagnosed with acute pulmonary embolism at Dicle University Hospital’s emergency department between January 2016 and December 2022. Receiver operating characteristic (ROC) curve analysis was used to examine the diagnostic decision properties of the variables used in mortality prediction. Results: 103 (91.96%) of the patients survived and 9 (8.04%) died. As a result, the best parameters for predicting mortality outcomes were NLPR (area under the curve (AUC): 0.887, sensitivity: 88.89%, specificity: 84.47%, positive predictive value (PPV): 33.33%, negative predictive value (NPV): 98.86%), NPR (AUC: 0.828, sensitivity: 77.78%, specificity: 91.26%, PPV: 43.75%, NPV: 97.92%), NLR (AUC: 0.803, sensitivity: 88.89%, specificity: 60.19%, PPV: 16.33%, NPV: 98.41%) respectively. Conclusions: This study found that NLPR, NPR and NLR were the most accurate complete blood parameters for predicting mortality in acute pulmonary embolism patients admitted to the emergency department.

Acute pulmonary embolism; Neutrophil-to-lymphocyte platelet ratio (NLPR); Neutrophil to lymphocyte ratio (NLR); Neutrophil to platelet ratio (NPR); Mortalite

[1] Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European Heart Journal. 2020; 41: 543–603.

[2] Begieneman MP, van de Goot FR, van der Bilt IA, Vonk Noordegraaf A, Spreeuwenberg MD, Paulus WJ, et al. Pulmonary embolism causes endomyocarditis in the human heart. Heart. 2008; 94: 450–456.

[3] Venetz C, Labarère J, Jiménez D, Aujesky D. White blood cell count and mortality in patients with acute pulmonary embolism. American Journal of Hematology. 2013; 88: 677–681.

[4] Lin W, Wu Y, Lu X, Hu Y. Association between mean platelet volume and pulmonary embolism: a systematic review and meta-analysis. Aging. 2021; 13: 17253–17273.

[5] Ma Y, Mao Y, He X, Sun Y, Huang S, Qiu J. The values of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting 30 day mortality in patients with acute pulmonary embolism. BMC Cardiovascular Disorders. 2016; 16: 123.

[6] Uzunosmanoğlu H, Çorbacıoğlu ŞK, Şafak T, Dağar S, Emektar E, Çevik Y. Prognostic value of platelet mass index in pulmonary emboli in the emergency department. Annals of Clinical and Analytical Medicine. 2012; 12: 402–406.

[7] Kasapoğlu US, Olgun Yıldızeli Ş, Arıkan H, Erer A, Kabadayı F, Yalçınkaya E, et al. Comparison of neutrophil to lymphocyte ratio with other prognostic markers affecting 30 day mortality in acute pulmonary embolism. Tuberculosis and Thorax. 2019; 67: 179–189.

[8] Obradovic S, Dzudovic B, Subotic B, Salinger S, Matijasevic J, Benic M, et al. Association of blood leukocytes and hemoglobin with hospital mortality in acute pulmonary embolism. Journal of Clinical Medicine. 2023; 12: 6269.

[9] Karataş MB, İpek G, Onuk T, Güngör B, Durmuş G, Çanga Y, et al. Assessment of prognostic value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with pulmonary embolism. Acta Cardiologica Sinica. 2016; 32: 313–320.

[10] Soylu K, Gedikli Ö, Ekşi A, Avcıoğlu Y, Soylu Aİ, Yüksel S, et al. Neutrophil-to-lymphocyte ratio for the assessment of hospital mortality in patients with acute pulmonary embolism. Archives of Medical Science. 2016; 12: 95–100.

[11] Kundi H, Balun A, Cicekcioglu H, Cetin M, Kiziltunc E, Cetin ZG, et al. The relation between platelet-to-lymphocyte ratio and Pulmonary Embolism Severity Index in acute pulmonary embolism. Heart & Lung. 2015; 44: 340–343.

[12] Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Current Pharmaceutical Design. 2011; 17: 47–58.

[13] Wang Q, Ma J, Jiang Z, Ming L. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis. International Angiology. 2018; 37: 4–11.

[14] Kayrak M, Erdoğan HI, Solak Y, Akilli H, Gül EE, Yildirim O, et al. Prognostic value of neutrophil to lymphocyte ratio in patients with acute pulmonary embolism: a restrospective study. Heart, Lung and Circulation. 2014; 23: 56–62.

[15] Umut G, Ugur L, Irfan A, Kasim T, Erdal Y, Hakan K, et al. Clinical value of inflammatory biomarkers in determining severity of COVID-19. Journal of Acute Medicine. 2023; 13: 58–64.

[16] Hamad DA, Aly MM, Abdelhameid MA, Ahmed SA, Shaltout AS, Abdel-Moniem AE, et al. Combined blood indexes of systemic inflammation as a mirror to admission to intensive care unit in COVID-19 patients: a multicentric study. Journal of Epidemiology and Global Health. 2022; 12: 64–73.

[17] Li S, Yu S, Qin J, Peng M, Qian J, Zhou P. Prognostic value of platelet count-related ratios on admission in patients with pyogenic liver abscess. BMC Infectious Diseases. 2022; 22: 636.

[18] Su X, Zhao S, Zhang N. Admission NLPR predicts long-term mortality in patients with acute ischemic stroke: a retrospective analysis of the MIMIC-III database. PLOS ONE. 2023; 18: e0283356.

[19] Ghobadi H, Mohammadshahi J, Javaheri N, Fouladi N, Mirzazadeh Y, Aslani MR. Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients. Frontiers in Medicine. 2022; 9: 916453.

[20] Choudhury S, Dubey S, Zumu M, Mustafa P P M, Burma A, Kumar S. The role of platelet parameters in predicting the disease severity of COVID-19 patients: a hospital-based study. Cureus. 2024; 16: e51523.

[21] Lin Y, Dai W, Chen Y, He X, Xu Y. Neutrophil-to-platelet ratio predicts mortality following percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction. Frontiers in Physiology. 2022; 13: 1011048.

[22] Suwadi A, Tandarto K, Laksono S. Systemic immune-inflammation index as a potential biomarker for predicting acute pulmonary embolism: a systematic review. Romanian Journal of Internal Medicine. 2024; 62: 231–240.

[23] Siddiqui F, García-Ortega A, Kantarcioglu B, Sinacore J, Tafur A, Demelo-Rodríguez P, et al. Cellular indices and outcome in patients with acute venous thromboembolism. Clinical and Applied Thrombosis/Hemostasis. 2022; 28: 10760296221113346.